Aramark (ARMK) vs Dolby Laboratories (DLB)
Aramark and Dolby Laboratories are both Specialty Business Services companies. Aramark is the larger, with a market value of $14.3B against $5.4B — 2.7× the size. Dolby Laboratories trades at the lower P/E: 24.6× against 37.6×. Aramark grew revenue faster over the last twelve months: 11.0% against 0.55%. Dolby Laboratories has the higher net margin (16.7% vs 1.93%) and the higher return on invested capital (8.06% vs 6.03%). Both pay a dividend; Dolby Laboratories yields more (1.38% vs 1.37%). Across the 22 metrics below, Dolby Laboratories leads on 16 and Aramark on 6.
Valuation
Profitability
| Metric | ARMK | DLB | Specialty Business Services median |
|---|---|---|---|
| Gross margin | 8.51% | 87.61% | 35.31% |
| Operating margin | 4.39% | 17.65% | 3.43% |
| Net margin | 1.93% | 16.70% | 1.67% |
| Free cash flow margin | 2.34% | 26.66% | 3.28% |
| Return on equity | 11.82% | 8.69% | 0.58% |
| Return on assets | 2.81% | 7.12% | 0.33% |
| Return on invested capital | 6.03% | 8.06% | 0.65% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack